Rubina Perveen Shaikh

Title: Innovations in Pharmaceutical Delivery: The Contributions of Rubina Perveen Shaikh

Introduction

Rubina Perveen Shaikh is an innovative inventor based in Gauteng, South Africa. With her expertise in pharmaceutical sciences, she has made significant contributions to drug delivery systems. Her work focuses on developing advanced pharmaceutical dosage forms aimed at improving the efficacy and specificity of drug delivery.

Latest Patents

Rubina holds one patent titled "Pharmaceutical dosage form," which presents a novel pH responsive and mucoadhesive pharmaceutical dosage system. This invention describes a drug delivery mechanism that incorporates multiple membranous layers to achieve site-specific delivery of pharmaceutically active agents. The construction of the dosage form includes a mucoadhesive layer for targeted adhesion, a water-insoluble outer layer, and an intermediate layer that can comprise one or more active agents. The innovative design provides a reliable delivery system, ensuring that drugs are released at specific locations within the gastrointestinal tract, over designated periods, and with controlled release patterns.

Career Highlights

Rubina is associated with the University of the Witwatersrand in Johannesburg, where she engages in cutting-edge research in the field of pharmaceutical sciences. Her academic and professional pursuits have led her to explore comprehensive solutions for effective drug delivery, impacting both clinical and pharmaceutical practices.

Collaborations

Throughout her career, Rubina has worked alongside notable colleagues such as Viness Pillay and Yahya Essop Choonara. These collaborations have enriched her research and innovation efforts, highlighting the importance of teamwork in advancing scientific knowledge and technology.

Conclusion

Rubina Perveen Shaikh represents the forefront of innovation in pharmaceutical dosage forms. Her patent reflects a substantial advancement in drug delivery technology, promising enhanced therapeutic outcomes. As she continues her research and development at the University of the Witwatersrand, the impact of her work will likely resonate well beyond the realm of pharmaceuticals, contributing to improved health care solutions globally.